BiotechTube

Azetukalner

Phase 3Recruiting
0 views this week 0 watching⚡ Active🧠Featured in Neuroscience Pipeline Watch
Interest: 44/100
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Bipolar Depression

Conditions

Bipolar Depression, Bipolar I Disorder, Bipolar Disorder, Bipolar II Disorder

Trial Timeline

Oct 30, 2025 → Aug 1, 2029

NCT ID
NCT07217860

About Azetukalner

Azetukalner is a phase 3 stage product being developed by Xenon Pharmaceuticals for Bipolar Depression. The current trial status is recruiting. This product is registered under clinical trial identifier NCT07217860. Target conditions include Bipolar Depression, Bipolar I Disorder, Bipolar Disorder.

What happened to similar drugs?

20 of 20 similar drugs in Bipolar Depression were approved

Approved (20) Terminated (3) Active (0)
✅Olanzapine + PlaceboEli LillyApproved
✅OlanzapineEli LillyApproved
✅OlanzapineEli LillyApproved
✅olanzapine + divalproex sodium + placeboEli LillyApproved
✅olanzapine + risperidoneEli LillyApproved
✅Topiramate + PlaceboEli LillyApproved
✅Olanzapine Fluoxetine Combination (OFC) + PlaceboEli LillyApproved

Hype Score Breakdown

Clinical
17
Activity
15
Company
12
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT07217860Phase 3Recruiting
NCT06922110Phase 3Recruiting

Competing Products

20 competing products in Bipolar Depression

See all competitors
ProductCompanyStageHype Score
OlanzapineEli LillyPhase 3
32
Valproate + Lithium + Risperidone + OlanzapineEli LillyPhase 3
40
Olanzapine + PlaceboEli LillyApproved
43
FK949EAstellas PharmaPhase 3
40
FK949EAstellas PharmaPhase 3
40
FK949E + PlaceboAstellas PharmaPhase 2/3
38
Escitalopram + Bupropion XLLupin LimitedPhase 3
32
OlanzapineEli LillyApproved
43
Olanzapine Hydrochloride + Lithium CarbonateEli LillyPhase 3
40
olanzapine + lithium + valproate + carbamazepineEli LillyPhase 3
40
OlanzapineEli LillyApproved
43
OlanzapineEli LillyPhase 3
40
LY2979165 + PlaceboEli LillyPhase 1
29
olanzapine + divalproex sodium + placeboEli LillyApproved
43
olanzapine + risperidoneEli LillyApproved
43
LY2979165 + placeboEli LillyPhase 1
29
Topiramate + PlaceboEli LillyApproved
43
olanzapineEli LillyPhase 3
40
Olanzapine + PlaceboEli LillyPhase 3
40
Brenipatide + PlaceboEli LillyPhase 2
42